Entries by circlek

Ann Hacker joins Karus board

Southampton, UK – 2 April 2008 – Innovative pharmaceutical company Karus Therapeutics Ltd has today announced that Ann Hacker has joined the company’s board as an independent non-executive director. Ann brings substantial experience of senior management and corporate governance gained in major pharmaceutical and VC-backed biotechnology companies, which will support Karus’s continued growth and success. […]

Karus appoints Stephen Shuttleworth as Chief Scientific Officer

Southampton, UK – 1 January 2008 – Innovative pharmaceutical company Karus Therapeutics Ltd has today announced the appointment of Dr Stephen J Shuttleworth FRSC to the position of Chief Scientific Officer. Dr Shuttleworth brings substantial R&D management experience gained from major life-science companies on both sides of the Atlantic and will play a key part […]

Karus Scientist presents at key industry conferences

Southampton, UK – 23 October 2007 – Innovative pharmaceutical company Karus Therapeutics make presentations at two key industry conferences: the CHI „Discovery on Target‟ conference (Boston, MA) and the American Association for Cancer Research (AACR) conference (San Francisco, CA). In both presentations Professor Graham Packham, one of Karus’s founders, highlighted the progress made with Karus’s […]

Karus signs co-development agreement with EOS

Southampton, UK – 1 October 2007 – Innovative pharmaceutical company Karus Therapeutics Ltd has entered a co-development agreement with EOS SpA (Milan, Italy) to discover and develop new anti-cancer drugs based on Karus’s unique therapeutics platform. As part of the collaboration, Karus and EOS aim to develop a new drug through human Phase IIA cancer […]

Karus raises £0.82 million investment

Southampton, UK – 1 July 2007 – Innovative pharmaceutical company Karus Therapeutics Ltd has today announced the closing of a £0.82 million investment, led by the company’s Chairman, Drummond Paris. Investors also included a consortium of high net worth individuals and reference Angels and the IP Venture Fund. The investment will be used to further […]

Drummond Paris named as Chairman of Karus Therapeutics

Southampton, UK – 12 October 2006 – Innovative biopharmaceutical company Karus Therapeutics has appointed Drummond Paris as Chairman. He is currently President of Kowa Research Europe Ltd and was formerly CEO of Novartis Pharmaceuticals UK. The University of Southampton spin-out was created by in July 2005 by Dr A. Ganesan from the School of Chemistry, […]

Karus Therapeutics appoints Simon Kerry as CEO

Southampton, UK – 2 May 2006 – Karus Therapeutics, an emerging biotechnology company and University of Southampton spinout, focused on developing innovative therapeutics to treat cancer and heart disease, has announced the appointment of Simon Kerry as its Chief Executive Officer (CEO). Simon joins Karus from a senior business development position with a European biotech […]

Collaboration with Sareum Holdings

Southampton, UK – 13 December 2005 – Karus Therapeutics is pleased to announce it has entered into a collaborative agreement with AIM-listed Sareum Holdings plc, a specialist structure-based drug discovery and services business. Sareum will provide computational chemistry expertise to support Karus’s therapeutic discovery programmes based on inhibitors of histone deacetylase (HDAC). Financial terms of […]